As of 2025-12-19, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (23.25) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -496.1%.
The range of the Relative Valuation is (20.70) - (22.78) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 23.7x | 21.4x |
| Forward P/E multiples | 21.5x - 32.4x | 27.0x |
| Fair Price | (20.70) - (22.78) | (23.25) |
| Upside | -452.6% - -488.0% | -496.1% |
| Date | P/E |